Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.019 | 0.8 |
mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.058 | 0.8 |
mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |